… days before starting BV treatment, and whether BV was used in the first-line setting for
mCRC were collected to analyze the risk factors for complications requiring surgery. In addition, …

… Preoperative serum VEGF levels have also been shown to correlate … of bevacizumab in
combination with 5-FU/LV as first-line chemotherapy in patients with metastatic colorectal cancer […

… bevacizumab/mFOLFOX‐6. Our results suggest that Ang‐2 is not a relevant therapeutic target
in first‐line … , low Ang‐2 baseline levels correlated with better PFS and OS [15, 16]. These …

… or sequentially, strongly correlates with median survival in … arterial hypertension, proteinuria,
arterial thrombotic events, … tumors, first-line treatment should include bevacizumab plus …

… the approval of bevacizumab for the treatment of first-line mCRC.7 This … on clinical outcomes.
The purpose of this analysis was twofold: to examine whether longer use of BBP correlated …

… Moreover, bevacizumab-induced hypertension is associated … first-line therapy was ≥ 6
months in 22 (25%) patients; nine (… REGARD trial or in colorectal cancer patients who received …

… overall survival (OS) in metastatic colorectal cancer (mCRC) and that … All patients were
treated according to standard first-line … developed during bevacizumab therapy are correlated to …

… in colorectal cancer [9] and in non-small cell lung cancer [10]. … progression on standard first
line treatment with dacarbazine (… assessed for subsequent correlation with clinical outcome. …

… HTN is correlated with response to second line treatment with … to treatment with bevacizumab
in metastatic colorectal cancer … from the last dose of first-line platinum and fluoropyrimidine …

… First‐line treatment for metastatic colorectal cancer (mCRC) typically entails a biologic such
as bevacizumab (… in STEAM had BRAF‐mutated disease to allow correlation with outcomes. …